Thoracic ultrasound is increasingly considered to be an essential tool for the pulmonologist.
It is used in diverse clinical scenarios, including as an adjunct to clinical decision making for …

Malignant pleural effusion (MPE) is a common but serious condition that is related with poor
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Malignant pleural effusions are common in patients with cancer. Most malignant pleural
effusions are secondary to metastases to the pleura, most often from lung or breast cancer …

Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by
asbestos exposure several decades before symptoms arise. Despite widespread prohibition …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Malignant pleural effusion (MPE) is one of the commonest causes of an exudative pleural
effusion, and its incidence is increasing with increasing cancer prevalence and as more …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Introduction: Pleural effusion is a common clinical problem. Yet, in a significant proportion of
patients (~ 20%), the cause of pleural effusion remains unknown. Understanding the …

Background: Diagnostic yield (DY) and safety of computed tomography (CT)-and thoracic
ultrasound (TUS)-guided biopsies in the diagnosis of pleural lesions have been investigated …